Health Canada inspection
Montreal Neurological Institute: Health Canada inspection of May 21, 2026
Health Canada · GMP · rating C
Key facts
| Establishment | Montreal Neurological Institute |
|---|---|
| City | Montreal |
| Province | Quebec |
| Country | Canada |
| Program | GMP |
| Start date | May 20, 2026 |
| End date | May 21, 2026 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 101802 |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.